tm
Seeing Is Believing
tm
Seeing Is Believing
AUPH is currently covered by 3 analysts with an average price target of $25.61. This is a potential upside of $9.82 (62.19%) from yesterday's end of day stock price of $15.79.
Aurinia Pharmaceuticals's activity chart (see below) currently has 113 price targets and 68 ratings on display. The stock rating distribution of AUPH is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 67.33% with an average time for these price targets to be met of 430.25 days.
Highest price target for AUPH is $21, Lowest price target is $8, average price target is $14.5.
Most recent stock forecast was given by MAURY RAYCROFT from JEFFERIES on 07-Nov-2025. First documented stock forecast 30-Jun-2016.
Currently out of the existing stock ratings of AUPH, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$21
$4.63 (28.28%)
$6
1 months 10 days ago
(07-Nov-2025)
3/4 (75%)
$7.05 (50.54%)
398
Buy
$8
$-8.37 (-51.13%)
$8
9 months 19 days ago
(28-Feb-2025)
9/13 (69.23%)
$0.05 (0.63%)
135
Buy
$13
$-3.37 (-20.59%)
$13
1 years 3 months 11 days ago
(06-Sep-2024)
16/22 (72.73%)
$5.74 (79.06%)
626
Hold
$13
3 years 1 months 13 days ago
(04-Nov-2022)
6/9 (66.67%)
$4.73 (57.19%)
359
Buy
$12
$-4.37 (-26.70%)
$22
3 years 1 months 13 days ago
(04-Nov-2022)
1/4 (25%)
$6.85 (133.01%)
266
What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?
Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?
Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?
